← Open Payments lookup

RAVI KUMAR SINGAREDDY: Open Payments

NPI 1407809122 · SUWANEE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$808 in 37 payments from 14 companies in 2025. Trend: 2023 $226 · 2024 $409 · 2025 $808

Food & beverage: $808
CompanyPaymentsAmount
Janssen Pharmaceuticals, Inc8$203
Neurocrine BioSciences, Inc.5$107
Takeda Pharmaceuticals U.S.A., Inc.4$85
ABBVIE INC.4$73
Vanda Pharmaceuticals Inc.3$67
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Otsuka America Pharmaceutical, Inc.3$56
QOL Medical, LLC1$30
E.R. Squibb & Sons, L.L.C.1$29
IDORSIA PHARMACEUTICALS US INC1$24

Products named: INVEGA SUSTENNA, TRINTELLIX, INGREZZA, VRAYLAR, CAPLYTA, REXULTI, SPRAVATO, HETLIOZ.

Industry payments across GA — which companies pay providers there.